The one-year price target for ST Pharm Co. (KOSDAQ:237690) has been raised to ₩159,212.73 per share, reflecting a 16.85% increase from the previous estimate of ₩136,255.00 as of February 1, 2026. The new target range established by analysts spans from a low of ₩101,000.00 to a high of ₩210,000.00 per share, which represents a 4.54% increase over the latest closing price of ₩152,300.00 per share.
ST Pharm Co. currently maintains a dividend yield of 0.33% and a payout ratio of 0.28, indicating a sustainable distribution of income to shareholders. The company saw a 25% decrease in the number of institutional owners, dropping to 24 funds. Total institutional shares owned decreased by 26.20% to 446,000 shares over the last three months.
Among major stakeholders, Vanguard Total International Stock Index Fund holds 175,000 shares (0.84% ownership), a slight increase from the previous quarter. Vanguard FTSE All-World ex-US Small-Cap Index Fund has increased its stakes to 40,000 shares (0.19% ownership). Meanwhile, the Emerging Markets Core Equity Portfolio and others maintained their positions without change.
